BTC$64,010.00-1.38%
ETH$1,870.80-2.78%
USDT$0.9992-0.02%
BNB$574.38-1.11%
USDC$0.99980.00%
XRP$1.09-2.21%
SOL$75.55-2.52%
TRX$0.3233-0.37%
FIGR_HELOC$1.00-3.32%
HYPE$61.70-7.90%
DOGE$0.0728-1.62%
USDS$0.9997-0.01%
RAIN$0.0148+1.24%
ZEC$538.08-6.68%
LEO$9.79-0.19%
WBT$55.97-1.63%
BTC$64,010.00-1.38%
ETH$1,870.80-2.78%
USDT$0.9992-0.02%
BNB$574.38-1.11%
USDC$0.99980.00%
XRP$1.09-2.21%
SOL$75.55-2.52%
TRX$0.3233-0.37%
FIGR_HELOC$1.00-3.32%
HYPE$61.70-7.90%
DOGE$0.0728-1.62%
USDS$0.9997-0.01%
RAIN$0.0148+1.24%
ZEC$538.08-6.68%
LEO$9.79-0.19%
WBT$55.97-1.63%
Evoke Pharma shares soared 25% in premarket trading after announcing FDA Orange Book listing of a new GIMOTI patent extending protection to 2038.